Emerging Pharma

Driving Commercial Excellence in Rare Diseases Biopharma Through a Unified Commercial Analytics Platform

How AI-powered analytics accelerated launch execution and patient access
Download Case Study

Discover how a leading biopharma innovator in RNA-targeted therapeutics partnered with Axtria to build a centralized commercial analytics platform, enabling rapid product launches, enhanced patient access and adherence, and sustained commercial growth.

With two upcoming product launches and multiple Phase 3 trials, the client sought a scalable data and analytics backbone to power its commercial expansion. However, the client faced typical rare disease commercialization challenges, scattered SP data, manual reporting, limited visibility into patient journeys, and operational silos slowing execution.

Axtria’s Solution: Building a Unified Commercial Analytics Platform

Axtria partnered with the client to architect a governed, AI-powered data platform that connects commercial, medical, and HEOR functions. The platform unified diverse data sources, CRM, SP, patient services, and market access to deliver real-time, cross-functional insights and immediately enhanced SP data accuracy and patient journey visibility. Together with stakeholders, Axtria developed a governed data warehouse and semantic model while co-designing quality and governance frameworks to standardize specialty pharmacy (SP) data management.

Key implementation components included:

1. Governed Commercial Data Warehouse

A centralized analytics foundation built on Databricks, enabling scalable ingestion, transformation, and analytics of high-volume commercial and patient data.

2. Specialty Pharmacy Data Aggregation

Powered by Axtria DataMAx™, standardizing, validating, and harmonizing prescriber, patient, and prescription data across SP feeds for consistent business use.

3. Automated Quality & Compliance Engine

A metadata-driven rules framework enabling:

  • Automated data quality checks
  • SLA monitoring
  • Governance workflows
  • Regulatory compliance controls

This foundation produced standardized data models, reporting-ready datasets, and persona-based dashboards serving stakeholders across commercial, access, HEOR, and medical teams.

Measurable Business Impact

The unified commercial analytics platform delivered transformative results:

  • 35% reduction in data preparation time through workflow automation and standardized pipelines.
  • 3× productivity improvement powered by Axtria DataMAx™ self-service modules for data validation, cataloging, and provisioning.
  • 45+ commercial use cases operationalized across segmentation, forecasting, contracting, IC, and HEOR.
  • 80+ interactive dashboards deployed, providing near-real-time insights to commercial, market access, and medical teams.

By unifying data operations through Axtria’s agentic AI platform and strategic consulting expertise, the biopharma organization successfully built scalable commercial capabilities while strengthening its launch readiness and financial trajectory. The integrated analytics ecosystem delivered measurable increases in prescription volume, patient adoption, and operational efficiency providing the organization full ownership of its analytics strategy and execution.

FAQs

Complete the brief form to download the case study

Recommended insights

driving-commercial-excellence-in-rare-diseases-biopharma-through-a-unified-commercial-analytics-platform

Case Study

Driving Commercial Excellence in Rare Diseases Biopharma Through a Unified Commercial Analytics Platform
driving-commercial-excellence-in-rare-diseases-biopharma-through-a-unified-commercial-analytics-platform

Case Study

AI-Fueled NBA Delivers 21% Stronger TRx Performance in Under a Year: A Win for Top Biopharma
driving-commercial-excellence-in-rare-diseases-biopharma-through-a-unified-commercial-analytics-platform

White Paper

Forecasting the Unknown: Why Rare Disease Projections Fail and How to Fix Them